163 related articles for article (PubMed ID: 19734845)
1. Diagnostic utility of IMP3 in segregating metastatic melanoma from benign nevi in lymph nodes.
Mentrikoski MJ; Ma L; Pryor JG; McMahon LA; Yang Q; Spaulding BO; Scott GA; Wang HL; Xu H
Mod Pathol; 2009 Dec; 22(12):1582-7. PubMed ID: 19734845
[TBL] [Abstract][Full Text] [Related]
2. Fatty Acid Synthase and Acetyl-CoA Carboxylase Are Expressed in Nodal Metastatic Melanoma But Not in Benign Intracapsular Nodal Nevi.
Saab J; Santos-Zabala ML; Loda M; Stack EC; Hollmann TJ
Am J Dermatopathol; 2018 Apr; 40(4):259-264. PubMed ID: 28654463
[TBL] [Abstract][Full Text] [Related]
3. 5-Hydroxymethylcytosine expression in metastatic melanoma versus nodal nevus in sentinel lymph node biopsies.
Lee JJ; Granter SR; Laga AC; Saavedra AP; Zhan Q; Guo W; Xu S; Murphy GF; Lian CG
Mod Pathol; 2015 Feb; 28(2):218-29. PubMed ID: 25081754
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic utility of neural stem and progenitor cell markers nestin and SOX2 in distinguishing nodal melanocytic nevi from metastatic melanomas.
Chen PL; Chen WS; Li J; Lind AC; Lu D
Mod Pathol; 2013 Jan; 26(1):44-53. PubMed ID: 22899289
[TBL] [Abstract][Full Text] [Related]
5. IMP-3 is a novel progression marker in malignant melanoma.
Pryor JG; Bourne PA; Yang Q; Spaulding BO; Scott GA; Xu H
Mod Pathol; 2008 Apr; 21(4):431-7. PubMed ID: 18204432
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemistry for PRAME in the Distinction of Nodal Nevi From Metastatic Melanoma.
Lezcano C; Pulitzer M; Moy AP; Hollmann TJ; Jungbluth AA; Busam KJ
Am J Surg Pathol; 2020 Apr; 44(4):503-508. PubMed ID: 31633488
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of BRAF V600E mutational status in capsular nevi of sentinel lymph nodes in patients with primary cutaneous melanoma.
Siroy AE; Aung PP; Torres-Cabala CA; Tetzlaff MT; Nagarajan P; Milton DR; Curry JL; Ivan D; Prieto VG
Hum Pathol; 2017 Jan; 59():48-54. PubMed ID: 27666765
[TBL] [Abstract][Full Text] [Related]
8. Differential gene expression profiling of primary cutaneous melanoma and sentinel lymph node metastases.
Koh SS; Wei JP; Li X; Huang RR; Doan NB; Scolyer RA; Cochran AJ; Binder SW
Mod Pathol; 2012 Jun; 25(6):828-37. PubMed ID: 22411186
[TBL] [Abstract][Full Text] [Related]
9. The prognostic significance of isolated immunohistochemically positive cells in sentinel lymph nodes of melanoma patients.
Murali R; Thompson JF; Shaw HM; Scolyer RA
Am J Surg Pathol; 2008 Jul; 32(7):1106-7; author reply 1107-8. PubMed ID: 18521043
[No Abstract] [Full Text] [Related]
10. CD63 expression in metastatic melanoma and melanocytic nevi in lymph nodes.
Mejia O; Vazquez T; Alexis J
Pathol Res Pract; 2021 Jul; 223():153464. PubMed ID: 34051511
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic utility of dual 5-hydroxymethylcytosine/Melan-A immunohistochemistry in differentiating nodal nevus from metastatic melanoma: An effective first-line test for the workup of sentinel lymph node specimen.
Siref AB; Huynh CAT; Balzer BL; Frishberg DP; Essner R; Shon W
J Cutan Pathol; 2019 Apr; 46(4):261-266. PubMed ID: 30632191
[TBL] [Abstract][Full Text] [Related]
12. Use of fluorescence in situ hybridization (FISH) to distinguish intranodal nevus from metastatic melanoma.
Dalton SR; Gerami P; Kolaitis NA; Charzan S; Werling R; LeBoit PE; Bastian BC
Am J Surg Pathol; 2010 Feb; 34(2):231-7. PubMed ID: 20087158
[TBL] [Abstract][Full Text] [Related]
13. Nodal melanocytic nevi in sentinel lymph nodes. Correlation with melanoma-associated cutaneous nevi.
Holt JB; Sangueza OP; Levine EA; Shen P; Bergman S; Geisinger KR; Creager AJ
Am J Clin Pathol; 2004 Jan; 121(1):58-63. PubMed ID: 14750241
[TBL] [Abstract][Full Text] [Related]
14. Serological reagents for the immunohistochemical analysis of melanoma metastases in sentinel lymph nodes.
Jungbluth AA
Semin Diagn Pathol; 2008 May; 25(2):120-5. PubMed ID: 18697716
[TBL] [Abstract][Full Text] [Related]
15. Benign melanocytic lymph node deposits in the setting of giant congenital melanocytic nevi: the large congenital nodal nevus.
Bowen AR; Duffy KL; Clayton FC; Andtbacka RH; Florell SR
J Cutan Pathol; 2015 Nov; 42(11):832-9. PubMed ID: 26268779
[TBL] [Abstract][Full Text] [Related]
16. Clinical relevance of sentinel lymph node status examined with conventional histology and molecular biology.
Micciolo R; Boi S; Paoli L; Cristofolini P; Girlando S; Dalla Palma P; Cristofolini M
Tumori; 2009; 95(3):298-302. PubMed ID: 19688967
[TBL] [Abstract][Full Text] [Related]
17. Nodal blue nevus: a pitfall in lymph node biopsies.
Dohse L; Ferringer T
J Cutan Pathol; 2010 Jan; 37(1):102-4. PubMed ID: 19615001
[TBL] [Abstract][Full Text] [Related]
18. Detection of tyrosinase mRNA in the sentinel lymph nodes of melanoma patients is not a predictor of short-term disease recurrence.
Tatlidil C; Parkhill WS; Giacomantonio CA; Greer WL; Morris SF; Walsh NM
Mod Pathol; 2007 Apr; 20(4):427-34. PubMed ID: 17334354
[TBL] [Abstract][Full Text] [Related]
19. Nevus cells in lymph nodes: an association with congenital cutaneous nevi.
Fontaine D; Parkhill W; Greer W; Walsh N
Am J Dermatopathol; 2002 Feb; 24(1):1-5. PubMed ID: 11803273
[TBL] [Abstract][Full Text] [Related]
20. False-positive cells in sentinel lymph nodes.
Brennick JB; Yan S
Semin Diagn Pathol; 2008 May; 25(2):116-9. PubMed ID: 18697715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
